Logo Image
News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Event Calendar
Videos
VideosPeer ExchangeShorts
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Event Calendar
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Asembia AXS26 Summit|
Digital Editions|
Security
Advertisement
|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Advertisement

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Advertisement
Legal & Regulatory

Related Content

Advertisement
Amy Niles

Mid-Year Check-In: Is Patient Affordability Getting Worse?

ByAmy Niles,Stephen Appezzato
July 23rd 2026
Pharma Pulse

Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs

ByStephen Appezzato
July 23rd 2026
Siva Mohan, MD, Cofounder, President and Chief Medical Officer at RazorMetrics.

The Data Problem Behind Prescription Drug Waste

BySiva Mohan, MD
July 22nd 2026
Amy Niles

Mid-Year Check-In: Has Prior Auth Reform Delivered?

ByAmy Niles,Stephen Appezzato
July 22nd 2026
Los Angeles, USA - April 4, 2023 Novo Nordisk only editorial Stock information on the logo of the office facade | stockmarketvisuals - stock.adobe.com 1068642359

Why Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads

BySusan Haigney
July 21st 2026
Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

The Data Problem Behind Prescription Drug Waste

2

Pharma Pulse: Cardinal Health Bulks Up Home Care, Trump Unveils Phased Generics Tariffs

3

What Cold Chain Tech Trends Are Reshaping Pharma Logistics?

4

Mid-Year Check-In: Has Prior Auth Reform Delivered?

5

Why Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us